We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a complaint filed in the District Court of the Central District of California, Immunex asserts Sanofi and Regeneron infringed on the Immunex patent for Dupixent, which the FDA approved in March to treat atopic dermatitis, a form of eczema. Read More
A federal judge has ruled that a class-action antitrust lawsuit against several generics manufacturers, alleging price-fixing of propranolol capsules and tablets, can proceed in court. Read More
GlaxoSmithKline has asked the U.S. Supreme Court to rule on the proper jurisdiction for a suit over birth defects and its antidepressant Paxil. Read More
The Maryland state legislature has approved a bill to ban excessive price increases for generics and off-patent drugs, and is sending it to the state’s governor for final approval. Read More